Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,567 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,567 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,567 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,567 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,567 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,567 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,567 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
22 Jan 2026
Yi Steven See Remarks
Sold on a plan
$89.62K 8,000 at 11.20
0.3%
Planned (10b5-1)
22 Jan 2026
Cohlhepp Ryan President and COO
Sold on a plan
$69.30K 3,828 at 18.10
1.8%
Planned (10b5-1)
22 Jan 2026
Michaelson Jennifer Chief Scientific Officer
Sold on a plan
$49.20K 4,000 at 12.30
3.0%
Planned (10b5-1)
22 Jan 2026
Bellon Christine Chief Legal Officer
Sold on a plan
$46.61K 1,371 at 34.00
1.4%
Planned (10b5-1)
22 Jan 2026
Vanderhook Christopher Chief Operating Officer · indirect
Sold on a plan
$33.13K 2,574 at 12.87
100%
Sold half or more
22 Jan 2026
WONG NELSON MUNPUN Senior Vice President
Sold on a plan
$12.00K 200 at 60.00
0.2%
Planned (10b5-1)
22 Jan 2026
Murphy Scott M Chief Accounting Officer
Sold on a plan
$9.70K 764 at 12.70
3.2%
Planned (10b5-1)
22 Jan 2026
Moreadith Randall Chief Scientific Officer
Sold on a plan
$7.38K 2,500 at 2.95
100%
Sold half or more
21 Jan 2026
Puri Ajay K EVP, Worldwide Field Ops · indirect
Sold on a plan
$36.01M 200,000 at 180.04
5.2%
Planned (10b5-1)
21 Jan 2026
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 9×
$25.81M 281,250 at 91.77
100%
Sold half or more
21 Jan 2026
KRAUSS SETH D See Remarks
Sold on a plan 13×
$2.82M 14,016 at 201.22
86.1%
Sold half or more
21 Jan 2026
TREFLER ALAN C.E.O. & Chairman
Sold on a plan 5×
$2.21M 45,000 at 49.02
0.1%
Planned (10b5-1)
21 Jan 2026
Maizel Ari Chief Commercial Officer
Sold on a plan
$1.38M 7,500 at 184.44
100%
Sold half or more
21 Jan 2026
Monroe Terilyn J. Chief People Officer
Sold on a plan 3×
$977.90K 8,571 at 114.09
29.0%
Planned (10b5-1)
21 Jan 2026
O'Melia Scott L. Chief Legal Officer
Sold on a plan
$750.00K 46,875 at 16.00
12.5%
Planned (10b5-1)
21 Jan 2026
Haris Clinton M. SVP & President, APS Division
Sold on a plan
$699.60K 5,830 at 120.00
13.4%
Planned (10b5-1)
21 Jan 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan 2×
$658.68K 9,333 at 70.58
0.4%
Planned (10b5-1)
21 Jan 2026
Bauer Jonathan S. Chief Investment Officer
Sold on a plan
$634.51K 3,105 at 204.35
10.6%
Planned (10b5-1)
21 Jan 2026
Gilliam Joseph E PRESIDENT & COO
Sold on a plan
$561.17K 4,502 at 124.65
4.6%
Planned (10b5-1)
21 Jan 2026
Goin Kathleen Chief Operating Officer
Sold on a plan 2×
$419.98K 4,302 at 97.63
100%
Sold half or more
21 Jan 2026
Quigg Andrew J Chief Strategy Officer
Sold on a plan
$336.97K 1,649 at 204.35
4.0%
Planned (10b5-1)
21 Jan 2026
Brown Sam D. SEVP, Chief Banking Officer
Sold on a plan
$182.86K 5,151 at 35.50
8.8%
Planned (10b5-1)
21 Jan 2026
Lopresti Angelo P SVP, Secretary & Gen Counsel
Sold on a plan
$127.50K 1,500 at 85.00
2.5%
Planned (10b5-1)
21 Jan 2026
Nottebohm Olivia Chief Operating Officer
Sold on a plan
$120.10K 4,612 at 26.04
1.0%
Planned (10b5-1)
21 Jan 2026
Rosenberg Nick Executive Vice President
Sold on a plan
$112.77K 1,250 at 90.21
4.6%
Planned (10b5-1)
21 Jan 2026
Cislini Jeff General Counsel
Sold on a plan
$104.96K 908 at 115.60
1.9%
Planned (10b5-1)
21 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$102.93K 438 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Tregillis Cynthia L Chief Legal Officer & Corp Sec
Sold on a plan
$102.36K 447 at 229.00
0.3%
Planned (10b5-1)
21 Jan 2026
Domino Michael Wayne Jr. President, DTR Division
Sold on a plan
$99.98K 24,996 at 4.00
1.7%
Planned (10b5-1)
21 Jan 2026
Yi Steven See Remarks
Sold on a plan
$88.18K 8,000 at 11.02
0.3%
Planned (10b5-1)
21 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$79.67K 339 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
O'Connor Casey Chief Legal Officer
Sold on a plan
$73.97K 13,852 at 5.34
2.5%
Planned (10b5-1)
21 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$68.86K 293 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Vanderhook Christopher Chief Operating Officer · indirect
Sold on a plan
$60.30K 4,926 at 12.24
65.7%
Sold half or more
21 Jan 2026
SMITH J. JEFFERSON Chief Research Officer
Sold on a plan
$41.11K 10,200 at 4.03
8.5%
Planned (10b5-1)
21 Jan 2026
Scimeca Dario General Counsel and Secretary
Sold on a plan
$35.68K 8,854 at 4.03
16.5%
Planned (10b5-1)
21 Jan 2026
Cree Brian President
Sold on a plan
$28.36K 1,440 at 19.69
0.3%
Planned (10b5-1)
21 Jan 2026
Platzer Peter Executive Chairman
Sold on a plan
$21.79K 1,801 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Kirol Charles Peter Chief Operating Officer
Sold on a plan
$19.90K 3,399 at 5.85
4.2%
Planned (10b5-1)
21 Jan 2026
Moreadith Randall Chief Scientific Officer
Sold on a plan
$6.00K 2,000 at 3.00
100%
Sold half or more
20 Jan 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 28×
$10.45M 22,500 at 464.66
100%
Sold half or more
20 Jan 2026
McBee Brannin Chief Development Officer
Sold on a plan 5×
$9.80M 102,835 at 95.29
29.3%
Planned (10b5-1)
20 Jan 2026
Biswas Sanjit CHIEF EXECUTVE OFFICER · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Bicket John SEE REMARKS · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Wong Jennifer L. Chief Operating Officer
Sold on a plan 9×
$6.13M 27,159 at 225.73
2.3%
Planned (10b5-1)
20 Jan 2026
McBee Brannin Chief Development Officer · indirect
Sold on a plan 35×
$6.08M 63,835 at 95.29
100%
Sold half or more
20 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
20 Jan 2026
Duda Kenneth President and CTO
Sold on a plan 4×
$3.85M 30,000 at 128.43
69.8%
Sold half or more
Showing 8,251–8,300 of 10,567. ← Newer Page 166 of 212 Older →